Ads
related to: glaxosmithkline- TUKYSA® (tucatinib)
Treatment Option
FDA Approved
- Patient Brochure
Learn about TUKYSA®
Explore More Here
- Explore FAQs Here
TUKYSA® (tucatinib) tablets
Frequently Asked Questions
- Important Safety Info
View Safety Information
For TUKYSA® (tucatinib) tablets
- Patient Resources
Read About TUKYSA®
Download Brochure & More
- What is TUKYSA®?
Benefits of Treatment
Learn More Here Today
- TUKYSA® (tucatinib)
Search results
Former GSK office building in Navy Yard set for sheriff's sale to satisfy $78M foreclosure judgment...
The Business Journals· 4 hours agoHailed for ushering in a new era of workspaces when it was built for pharmaceutical giant ...
Opinion | The Francis Scott Key bridge collapses, and Baltimore’s heart breaks
Washington Post· 4 hours agoWhen news came that there were six workers missing in the collapse of Baltimore’s Francis Scott Key...
Medicaid change sparks warning for children
Newsweek· 2 days agoA switch in Medicaid's formula could mean many children will go without inhalers in the coming months. The process change means drugmakers have to pay...
How corporate PAC money could end up in the personal coffers of Sens. JD Vance and Markwayne Mullin
Business Insider via Yahoo News· 4 hours agoMullin did the same with 19 corporate PACs, including ConocoPhillips, ExxonMobile, and ...
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
CNBC· 2 days agoThree of the world's largest inhaler makers have agreed to cap the out-of-pocket price of their...
Akebia stock jumps as FDA clears renal anemia therapy (NASDAQ:AKBA)
Seeking Alpha· 15 hours agoAkebia Therapeutics (AKBA) receives FDA approval for Vafseo tablets, leading to a 25% surge in...
Experts say Medicaid rebate change is behind inhaler price cuts - Roll Call
CQ Politics· 3 days agoThree of the four major inhaler manufacturers have announced plans to cap patient copays for all...
These Inhalers No Longer Cost More Than $35 Per Month
Verywell Health via Yahoo News· 2 days agoChanges were made in response to pressure from lawmakers. Amidst untenable drug prices, there's...
U.S. FDA approves Akebia's anemia drug
Reuters via Yahoo News· 24 hours agoThe FDA had earlier declined to approve vadadustat - a Hypoxia-inducible factor–prolyl hydroxylase (HIF-PH) inhibitor - on safety concerns, as it posed...
12 Best Biotech Penny Stocks to Invest In
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5...
Ad
related to: glaxosmithkline